7 results on '"Skrzypczak-Zielińska, Marzena"'
Search Results
2. Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease.
- Author
-
Zakerska-Banaszak, Oliwia, Łykowska-Szuber, Liliana, Walczak, Michał, Żuraszek, Joanna, Zielińska, Aleksandra, and Skrzypczak-Zielińska, Marzena
- Subjects
INFLAMMATORY bowel diseases ,CROHN'S disease ,ULCERATIVE colitis ,DRUG efficacy ,GUT microbiome ,DRUGS - Abstract
The effectiveness of thiopurine drugs in inflammatory bowel disease (IBD) was confirmed more than a half-century ago. It was proven that these can be essential immunomodulatory medications. Since then, they have been used routinely to maintain remission of Crohn's disease (CD) and ulcerative colitis (UC). The cytotoxic properties of thiopurines and the numerous adverse effects of the treatment are controversial. However, the research subject of their pharmacology, therapy monitoring, and the search for predictive markers are still very relevant. In this article, we provide an overview of the current knowledge and findings in the field of thiopurines in IBD, focusing on the aspect of their cytotoxicity. Due to thiopurines' benefits in IBD therapy, it is expected that they will still constitute an essential part of the CD and UC treatment algorithm. More studies are still required on the modulation of the action of thiopurines in combination therapy and their interaction with the gut microbiota. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications.
- Author
-
Skrzypczak, Dorota, Skrzypczak-Zielińska, Marzena, Ratajczak, Alicja Ewa, Szymczak-Tomczak, Aleksandra, Eder, Piotr, Słomski, Ryszard, Dobrowolska, Agnieszka, and Krela-Kaźmierczak, Iwona
- Subjects
MYOSTATIN ,FOLLISTATIN ,SARCOPENIA ,CROHN'S disease ,INFLAMMATORY bowel diseases ,DYSLIPIDEMIA - Abstract
Sarcopenia, which is a decrease in muscle strength and quality of muscle tissue, is a common disorder among patients suffering from inflammatory bowel disease. This particular group of patients often presents with malnutrition and shows low physical activity, which increases the risk of sarcopenia. Another important factor in the development of sarcopenia is an imbalanced ratio of myostatin and follistatin, which may stem from inflammation as well as genetic factors. Currently, research in this area continues, and is aimed at identifying an effective medication for the treatment of this condition. Additionally, we still have no sarcopenia markers that can be used for diagnosis. In this paper, we address the role of myostatin and follistatin as potential markers in the diagnosis of sarcopenia in patients with Crohn's disease and ulcerative colitis, particularly in view of the genetic and biological aspects. We also present data on new perspectives in the pharmacotherapy of sarcopenia (i.e., myostatin inhibitors and gene therapy). Nevertheless, knowledge is still scarce about the roles of follistatin and myostatin in sarcopenia development among patients suffering from inflammatory bowel disease, which warrants further study. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?
- Author
-
Rychter, Anna Maria, Skrzypczak-Zielińska, Marzena, Zielińska, Aleksandra, Eder, Piotr, Souto, Eliana B., Zawada, Agnieszka, Ratajczak, Alicja Ewa, Dobrowolska, Agnieszka, and Krela-Kaźmierczak, Iwona
- Subjects
- *
RETINOL-binding proteins , *DISEASE risk factors , *CAROTID intima-media thickness , *OBESITY , *CARDIOVASCULAR diseases , *ADIPOSE tissues , *CARDIOVASCULAR diseases risk factors - Abstract
Although many preventive and treatment approaches have been proposed, cardiovascular disease (CVD) remains one of the leading causes of deaths worldwide. Current epidemiological data require the specification of new causative factors, as well as the development of improved diagnostic tools to provide better cardiovascular management. Excessive accumulation of adipose tissue among patients suffering from obesity not only constitutes one of the main risk factors of CVD development but also alters adipokines. Increased attention is devoted to bioactive adipokines, which are also produced by the adipose tissue. The retinol-binding protein 4 (RBP4) has been associated with numerous CVDs and is presumably associated with an increased cardiovascular risk. With this in mind, exploring the role of RBP4, particularly among patients with obesity, could be a promising direction and could lead to better CVD prevention and management in this patient group. In our review, we summarized the current knowledge about RBP4 and its association with essential aspects of cardiovascular disease—lipid profile, intima-media thickness, atherosclerotic process, and diet. We also discussed the RBP4 gene polymorphisms essential from a cardiovascular perspective. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Vitamin C Deficiency and the Risk of Osteoporosis in Patients with an Inflammatory Bowel Disease.
- Author
-
Ratajczak, Alicja Ewa, Szymczak-Tomczak, Aleksandra, Skrzypczak-Zielińska, Marzena, Rychter, Anna Maria, Zawada, Agnieszka, Dobrowolska, Agnieszka, and Krela-Kaźmierczak, Iwona
- Abstract
Recent research studies have shown that vitamin C (ascorbic acid) may affect bone mineral density and that a deficiency of ascorbic acid leads to the development of osteoporosis. Patients suffering from an inflammatory bowel disease are at a risk of low bone mineral density. It is vital to notice that patients with Crohn's disease and ulcerative colitis also are at risk of vitamin C deficiency which is due to factors such as reduced consumption of fresh vegetables and fruits, i.e., the main sources of ascorbic acid. Additionally, some patients follow diets which may provide an insufficient amount of vitamin C. Moreover, serum vitamin C level also is dependent on genetic factors, such as SLC23A1 and SLC23A2 genes, encoding sodium-dependent vitamin C transporters and GSTM1, GSTP1 and GSTT1 genes which encode glutathione S-transferases. Furthermore, ascorbic acid may modify the composition of gut microbiota which plays a role in the pathogenesis of an inflammatory bowel disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study.
- Author
-
Mańkowska-Wierzbicka, Dorota, Stelmach-Mardas, Marta, Gabryel, Marcin, Tomczak, Hanna, Skrzypczak-Zielińska, Marzena, Zakerska-Banaszak, Oliwia, Sowińska, Anna, Mahadea, Dagmara, Baturo, Alina, Wolko, Łukasz, Słomski, Ryszard, and Dobrowolska, Agnieszka
- Subjects
ULCERATIVE colitis ,INFLAMMATORY bowel diseases ,FECAL microbiota transplantation ,BLOOD testing ,PILOT projects ,BACTEROIDES fragilis - Abstract
The modification of the microbiome through fecal microbiota transplantation (FMT) is becoming a very promising therapeutic option for inflammatory bowel disease (IBD) patients. Our pilot study aimed to assess the effectiveness of multi-session FMT treatment in active ulcerative colitis (UC) patients. Ten patients with UC were treated with multi-session FMT (200 mL) from healthy donors, via colonoscopy/gastroscopy. Patients were evaluated as follows: at baseline, at week 7, and after 6 months, routine blood tests (including C reactive protein (CRP) and calprotectin) were performed. 16S rRNA gene (V3V4) sequencing was used for metagenomic analysis. The severity of UC was classified based on the Truelove–Witts index. The assessment of microbial diversity showed significant differences between recipients and healthy donors. FMT contributed to long-term, significant clinical and biochemical improvement. Metagenomic analysis revealed an increase in the amount of Lactobacillaceaea, Micrococcaceae, Prevotellaceae, and TM7 phylumsp.oral clone EW055 during FMT, whereas Staphylococcaceae and Bacillaceae declined significantly. A positive increase in the proportion of the genera Bifidobacterium, Lactobacillus, Rothia, Streptococcus, and Veillonella and a decrease in Bacillus, Bacteroides, and Staphylococcus were observed based on the correlation between calprotectin and Bacillus and Staphylococcus; ferritin and Lactobacillus, Veillonella, and Bifidobacterium abundance was indicated. A positive change in the abundance of Firmicutes was observed during FMT and after 6 months. The application of multi-session FMT led to the restoration of recipients' microbiota and resulted in the remission of patients with active UC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's Disease.
- Author
-
Krela-Kaźmierczak, Iwona, Skrzypczak-Zielińska, Marzena, Kaczmarek-Ryś, Marta, Michalak, Michał, Szymczak-Tomczak, Aleksandra, Hryhorowicz, Szymon T., Szalata, Marlena, Łykowska-Szuber, Liliana, Eder, Piotr, Stawczyk-Eder, Kamila, Tomczak, Maciej, Słomski, Ryszard, and Dobrowolska, Agnieszka
- Subjects
- *
CROHN'S disease , *INFLAMMATORY bowel diseases , *BONE density , *WOMEN patients , *DUAL-energy X-ray absorptiometry - Abstract
Decreased bone mass in patients with inflammatory bowel diseases (IBD) is a clinical problem with extremely severe consequences of osteoporotic fractures. Despite its increasing prevalence and the need for mandatory intervention and monitoring, it is often ignored in IBD patients' care. Determining the biomarkers of susceptibility to bone mineral density disorder in IBD patients appears to be indispensable. We aim to investigate the impact of estrogen receptor gene (ESR1) gene polymorphisms on bone mineral density (BMD) in patients with ulcerative colitis (UC) and Crohn's disease (CD), as they may contribute both, to osteoporosis and inflammatory processes. We characterised 197 patients with IBD (97 with UC, 100 with CD), and 41 controls carrying out vitamin D, calcium and phosphorus serum levels, and bone mineral density assessment at the lumbar spine and the femoral neck by dual-energy X-ray absorptiometry (DXA), ESR1 genotyping and haplotype analysis. We observed that women with CD showed the lowest bone density parameters, which corresponded to the ESR1 c.454-397T and c.454-351A allele dose. The ESR1 gene PvuII and XbaI TA (px) haplotype correlated with decreased femoral neck T-score (OR = 2.75, CI = [1.21–6.27], P-value = 0.016) and may be predictive of osteoporosis in female patients with CD. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.